StockWatch
·

Ultragenyx Pharmaceutical Inc. Q2 FY26 Results

RAREQ2 FY26 Results
Filing
MetricValue ($ M)Q1 FY26Q2 FY25
Revenue214.0057.4%28.5%
Total Income214.0057.4%28.5%
Expenditure289.005.3%5.3%
PBT-91.0050.5%20.2%
Net Profit-92.0050.3%20.0%
OPM-35.05%29.75pp
NPM-42.99%26.05pp
EPS-0.9051.1%23.1%
View full financials

Informational and educational content only. Not investment advice.